What is the Role of Molecular Testing in Resectable Non–Small Cell Lung Cancer?

Shared insight from key opinion leaders on the value of molecular testing in patients with resectable non–small cell lung cancer and how it can be applied.

Related Keywords

,Recent Updates ,Translating Evidence ,Clinical Practice ,Molecular Testing ,Resectable Non ,Small Cell Lung ,Lung Cancer ,Non Small Cell Lung Cancer ,Nsclc ,Trio Therapy ,Immunotherapy ,Immune Checkpoint Inhibitors ,Genetic Testing ,Mutational Analysis ,Checkmate 816 ,Neoadjuvant Therapy ,Perioperative Therapy ,Neoadjuvant Chemotherapy ,Nivolumab Therapy ,Neoadjuvant Nivolumab ,Ngs Testing ,Next Generation Sequencing ,